Opaleye Management’s TELA Bio TELA Stock Holding History
Bought
Maintained
Sold
Other funds holding TELA
EWM
O
FLAM
ACM
NCM
PCM
SCM
Opaleye Management's TELA Position: Q4 2023 in Review
Opaleye Management sold out of TELA Bio (TELA) in Q4 2023, closing a stake of 750,000 shares — an estimated $6M sold.
Opaleye Management first reported a position in TELA in Q4 2019 and held it in 16 quarters. The position peaked at $23.8M in Q4 2022. 60 funds tracked by Wall St. Rank hold TELA as of Q4 2023.
- Opaleye Management reported no remaining TELA Bio position as of Q4 2023 after selling out during the quarter.
- Opaleye Management sold 750,000 TELA Bio shares in Q4 2023, an estimated $6M.
- Opaleye Management first reported a position in TELA Bio in Q4 2019 and held it in 16 quarters.
- Opaleye Management's TELA Bio position peaked at $23.8M in Q4 2022.
- 60 funds tracked by Wall St. Rank held TELA Bio as of Q4 2023.
Based on Opaleye Management's 13F filing for Q4 2023, filed 14 Feb 2024.